Pharmacyclics, Inc. Stock
Equities
US7169331060
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
2015 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 15-04-30 | |
Betty Chang
CTO | Chief Tech/Sci/R&D Officer | - | 13-07-08 |
Heow Tan
CTO | Chief Tech/Sci/R&D Officer | 65 | 12-04-30 |
1st Jan change | Capi. | |
---|---|---|
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- Stock